Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles-Reference-Cited by-同舟云学术

Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles

Published:2014-01-07 Issue:1 Volume:210 Page:99-110
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Goepfert Paul A.,Elizaga Marnie L.,Seaton Kelly,Tomaras Georgia D.,Montefiori David C.,Sato Alicia,Hural John,DeRosa Stephen C.,Kalams Spyros A.,McElrath M. Juliana,Keefer Michael C.,Baden Lindsey R.,Lama Javier R.,Sanchez Jorge,Mulligan Mark J.,Buchbinder Susan P.,Hammer Scott M.,Koblin Beryl A.,Pensiero Michael,Butler Chris,Moss Bernard,Robinson Harriet L.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Reference45 articles.

1. B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study;Nat Biotechnol,2012

2. Non-neutralizing antibodies in prevention of HIV infection;Expert Opin Biol Ther,2013

3. Emerging concepts on the role of innate immunity in the prevention and control of HIV infection;Annu Rev Med,2012

4. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand;N Engl J Med,2009

5. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand;J Infect Dis,2006

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of high shear rates on the average hydrodynamic diameter measured in biomimetic HIV Gag virus-like particle dispersions;Frontiers in Bioengineering and Biotechnology;2024-05-27

2. Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections;Vaccines;2024-04-29

3. The role of randomization inference in unraveling individual treatment effects in early phase vaccine trials;Statistical Communications in Infectious Diseases;2024-01-01

4. Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases;Signal Transduction and Targeted Therapy;2023-04-07

5. Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens;eBioMedicine;2022-10